These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 521095)

  • 1. Studies on immunotherapy in oral cancer patients with BCG and tumour antigens.
    Nir PN; Gangal SG; Rao RS
    Indian J Med Res; 1979 Aug; 70():252-62. PubMed ID: 521095
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy in patients with oral malignant disease.
    Perlin E
    Otolaryngol Clin North Am; 1979 Feb; 12(1):195-9. PubMed ID: 440739
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotherapy of carcinoma of the stomach: a status report.
    Edynak EM; Oishi N; Gordon BL; Deich A
    Hawaii Med J; 1977 Mar; 36(3):71-3. PubMed ID: 845017
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant immunotherapy in superficial bladder cancer.
    Morales A
    Natl Cancer Inst Monogr; 1978 Dec; (49):315-9. PubMed ID: 748787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer.
    McKneally MF; Maver C; Lininger L; Kausel HW; McIlduff JB; Older TM; Foster ED; Alley RD
    J Thorac Cardiovasc Surg; 1981 Apr; 81(4):485-92. PubMed ID: 7009993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunotherapy with oral BCG in cancer of the bladder].
    Netto Júnior NR; de Salvo Reinato JA; Teixeira LC; De Bellis N
    AMB Rev Assoc Med Bras; 1978 Oct; 24(10):358-60. PubMed ID: 311054
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of buccal epidermoid carcinoma. Up-to-date review].
    Reychler H
    Ann Chir Plast Esthet; 1991; 36(6):486-97. PubMed ID: 1726348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-surface expression of complement restriction factors and sialyl Lewis antigens in oral carcinoma: relevance to chemo-immunotherapy.
    Ravindranath NM; Nishimoto K; Chu K; Shuler C
    Anticancer Res; 2000; 20(1A):21-6. PubMed ID: 10769630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific and nonspecific immunotherapy as an adjunct to curative surgery for cancer of the lung.
    Hollinshead AC; Stewart TH
    Yale J Biol Med; 1981; 54(5):367-79. PubMed ID: 7039148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunotherapy with BCG-CWS (cell-wall skeleton) in patients with primary lung cancer (author's transl)].
    Takano T; Morishita M; Yamamoto M; Yamagata K; Takada K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1977 Nov; 15(11):769-74. PubMed ID: 606901
    [No Abstract]   [Full Text] [Related]  

  • 11. [Quantitative shifting of intra and peritumoral cell populations after intratumoral BCG-cell-wall therapy in squamous epithelial mouth neoplasms].
    Schlesinger S; Pickartz H; Bier J
    Dtsch Zahnarztl Z; 1980 Jan; 35(1):118-20. PubMed ID: 6931715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuraminidase treated cells and their role in cancer immunotherapy.
    Simmons RL; Rios A
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):223-8. PubMed ID: 4611534
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current status of immunotherapy of malignant tumors].
    Flad HD; Betzler M; Herfarth C
    Chirurg; 1979 Jan; 50(1):11-5. PubMed ID: 367730
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sapylin immunotherapy in oral squamous cancer].
    Lu CY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1990 Jul; 25(4):213-5, 252. PubMed ID: 2128234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy of lung cancer. I. Review of clinical trials in non-small cell histologic types.
    Mikulski SM; McGuire WP; Louie AC; Chirigos MA; Muggia FM
    Cancer Treat Rev; 1979 Sep; 6(3):177-90. PubMed ID: 394836
    [No Abstract]   [Full Text] [Related]  

  • 16. [BCG and levamisole in the treatment of advanced forms of lung cancer].
    Szafrański W
    Pneumonol Pol; 1980 Nov; 48(11):779-82. PubMed ID: 7255219
    [No Abstract]   [Full Text] [Related]  

  • 17. [The prevention of recurrences of surface bladder cancer by BCG vaccinal immunotherapy].
    Matveev BP; Kariakin OB; Safiullin KN; Figurin KM; Levi DT; Vatin OE
    Urol Nefrol (Mosk); 1993; (5):27-9. PubMed ID: 8310581
    [No Abstract]   [Full Text] [Related]  

  • 18. [Quantitative aspects of labeled plasma cell count in the demonstration of heavy and light immunoglobulin chains. (Findings in human oral squamous cell carcinomas before and after BCG treatment)].
    Jautzke G; Doering C
    Acta Histochem Suppl; 1982; 25():95-100. PubMed ID: 6806867
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunochemotherapy in cases of advanced laryngeal cancer].
    Singer Z; Kuśnierczyk W; Swierczyński Z; Swierczyśka B; Namyslowski G; Wróbel M
    Pol Tyg Lek; 1981 Jan; 36(4):141-4. PubMed ID: 7291075
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of the efficacy of different regimens of treating patients with cancer of the organs of the oral cavity].
    Kitsmaniuk ZD; Choĭnzonov EL
    Stomatologiia (Mosk); 1988; 67(4):44-6. PubMed ID: 3188101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.